Immunic, Inc. to Participate in Investor and Scientific Conferences in February

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at...

Related Keywords

Edna Kaplan ,Paula Schwartz ,Jessica Breu ,Evelyn Peelen ,Daniel Vitt ,Exchange Commission ,Colitis Organization ,Rx Communications Group ,Prnewswire Immunic Inc ,Nasdaq ,Immunic Inc ,Aegis Capital Corp ,Annual Global Healthcare ,Chief Executive Officer ,European Crohn ,Senior Manager Translational Pharmacology ,Small Molecule ,Ulcerative Colitis ,Shows Potent Anti Inflammatory Activity ,Vivo Systems ,Virtual Poster Exhibition ,Basic Science ,Aegis Capital ,Private Securities Litigation Reform Act ,Annual Report ,Investor Relations ,Immunic ,Nc ,